Search

Your search keyword '"Hadi, NR"' showing total 105 results

Search Constraints

Start Over You searched for: Author "Hadi, NR" Remove constraint Author: "Hadi, NR" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
105 results on '"Hadi, NR"'

Search Results

1. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021

2. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

4. A Comparative Study to illustrate the Effects of Beta-1 Adrenergic Receptor Allelic Polymorphism on Disease Outcome in Iraqi Patients with Acute Coronary Syndrome (on Metoprolol Therapy)

5. Association of Toll-Like Receptor (TLR-4) Gene Polymorphisms in Diabetic Kidney Disease: Iraqi Cohort Study

6. Effects of hydroxyurea on cerebral blood flow in sickle cell anemia patients

7. Decoding Oxidative Stress and Antioxidative Parameters in Patients with Spinal Cord Injury

8. Twelve-Week Mediterranean Diet Intervention Increases Citrus Bioflavonoid Levels and Reduces Inflammation in People with Type 2 Diabetes Mellitus

10. Prevalence of diet and lifestyle factors among patients with corona virus infection with reference to healthy subjects

12. Nephroprotective role of resveratrol in renal ischemia-reperfusion injury: a preclinical study in Sprague-Dawley rats.

13. Dysfunctional cardiac energy transduction, mitochondrial oxidative stress, oncogenic and apoptotic signaling in DiNP-induced asthma in murine model.

14. The Influence of OCT3 and MATE2 Genetic Polymorphisms in Poor Response to Metformin in Type 2 Diabetes Mellitus.

15. Impaired energy metabolism and altered brain histoarchitecture characterized by inhibition of glycolysis and mitochondrial electron transport-linked enzymes in rats exposed to diisononyl phthalate.

16. Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon.

17. The possible cardioprotective effect of ghrelin during experimental endotoxemia in mice.

18. Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle.

19. Influence of different factors (duration of disease, gender, education, patients' history, job and age) in metformin response in type 2 diabetes mellitus patient.

20. Diet control and BMI impact on Metformin response in type 2 Diabetes mellitus patients.

21. Effects of CDDO-EA in sepsis-induced acute lung injury: mouse model of endotoxaemia.

22. Cardamonin mitigates kidney injury by modulating inflammation, oxidative stress, and apoptotic signaling in rats subjected to renal ischemia and reperfusion.

23. Molecular and serological biomarkers to predict trastuzumab responsiveness in HER-2 positive breast cancer.

24. Regorafenib modulation of the angiopoietin/TIE2 axis in a mouse model of sepsis-induced lung injury.

25. Rebastinib attenuates liver injury following cecal ligation and puncture in male mice.

26. Effect of topical naringenin and its combination with minoxidil on enhancing hair growth in a mouse model.

27. Assessing the cardioprotective effect of necrosulfonamide in doxorubicin-induced cardiotoxicity in mice.

28. Targeting VEGF using Bevacizumab attenuates sepsis-induced liver injury in a mouse model of cecal ligation and puncture.

29. Neuroprotective effects of Coenzyme Q10 in ischemia-reperfusion injury via inflammation and oxidative stress reduction in adult male rats.

30. Potential nephroprotective effects of angiotensin II type 2 receptor agonist Compound 21 in renal ischemia-reperfusion injury.

31. Ameliorative effect of nebivolol in doxorubicin-induced cardiotoxicity.

32. Coq10 for preventing cardiotoxicity in breast cancer patients treated with trastuzumab.

33. The potential renoprotective effect of Raloxifene in renal ischemia-reperfusion injury in a male rat model.

34. Oridonin supplementation attenuates atherosclerosis via NLRP-3 inflammasome pathway suppression.

35. Effect of Sulforaphane on cardiac injury induced by sepsis in a mouse model: Role of toll-like receptor 4.

36. Xanthohumol ameliorates cardiac injury induced by sepsis in a mice model: role of toll-like receptor 4.

37. Role of Iberin as an anti-apoptotic agent on renal ischemia-reperfusion injury in rats.

38. NHWD-870 protects the kidney from ischemia/reperfusion injury by upregulating the PI3K/AKT signaling pathway (experimental study).

39. Lung protective effect of Ticagrelor in endotoxemia.

40. The effect of evolocumab alone and in combination with atorvastatin on atherosclerosis progression and TLRs expression.

41. The effect of JQ1 systemic administration on oxidative stress and apoptotic markers in renal ischemic reperfusion injury in a rat model.

42. Protective effect of IAXO-102 on renal ischemia-reperfusion injury in rats.

43. Stress as a possible cause of a high incidence of hypertension and diabetes and a low incidence of asthma in the Iraqi population.

44. Evaluation of anti-atherosclerotic effects of Sitagliptin via modulation of the mTOR pathway in male rabbits.

45. Investigating the renoprotective effect of C21 in male mice with sepsis via modulation of p-AKT/PI3K expression.

46. Semaglutide in renal ischemia-reperfusion injury in mice.

47. ASSESSMENT OF THE ASSOCIATION OF SEROTONIN TRANSPORTER GENE (5-HTTVNTR & 5-HTTLPR) POLYMORPHISM IN PATIENTS WITH FIBROMYALGIA SYNDROME.

48. THE POTENTIAL RENOPROTECTIVE EFFECT OF TILIANIN IN RENAL ISCHEMIA REPERFUSION INJURY IN MALE RAT MODEL.

49. LUNG PROTECTIVE EFFECTS OF CLOPIDOGREL IN POLYMICROBIAL SEPSIS.

50. ASSOCIATION OF SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B1 GENE POLYMORPHISM WITH RESPONSE TO ATORVASTATIN AND ASSOCIATED MYOPATHY IN IRAQI DYSLIPIDEMIA PATIENTS.

Catalog

Books, media, physical & digital resources